Wafaa Gaber
Cairo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Wafaa Gaber.
International Journal of Rheumatic Diseases | 2017
Amira A. Shahin; Hanan Hussein; Wafaa Gaber; Tamer Elbaz; Lamia Adel Salah El Din
Hepatitis C virus (HCV) is sialotropic. The pathogenesis of sicca manifestations in patients with chronic HCV infection is not fully understood. We aimed to detect changes in magnetic resonance sialography (MRS) of HCV patients with and without vasculitis.
Middle East Journal of Internal Medicine | 2015
Safaa Sayed; Wafaa Gaber; Waleed Hammam; Ahmad Al-ghitany; Ahmed H. K. Abdelmaksoud
Objective: This study aimed to detect incidence of subclinical arthritis in patients with NHL and the diagnostic ability of PDUS in detecting subclinical hyperuricemia. Methods: We studied 100 NHL patients (divided into 2 groups depending on the presence of the double contour (DC) sign detected by PDUS) and 100 controls in a cross sectional study. Demographic, clinical and serological data were evaluated. PDUS was done to all patients and controls. Results: There was a statistically significant difference between the two groups regarding the presence of subclinical hyperuricemia in group (1)(p=0.008) who had higher s. creatinine and gouty nephropathy (p=0.002 and p=0.001 respectively). Conclusion: PDUS can detect subclinical hyperuricemia and subsequent inflammatory arthritis in NHL patients; also it serves as a non-invasive, bedside tool.
Comparative Haematology International | 2015
Hoiyda A. Abdel Rasol; Wafaa Gaber; Margeret A. Aziz; Abeer Galal Eldin Rabie
High-mobility group box protein-1 (HMGB1) is identified as a pro-inflammatory mediator of tissue injury. Interferon-gamma (IFN-γ) dose dependently induced the release of HMGB1. The understanding of systemic lupus erythematosus (SLE) cytokine networks is very important for SLE treatment strategy and drug development. The purpose of this study is to determine the association of HMGB1 and IFN-γ levels to lupus nephritis and their relation to disease activity, autoantibodies, and certain laboratory parameters. The study population consisted of 50 lupus nephritis patients compared to 30 age- and sex-matched healthy controls (HC). HMGB1 and IFN-γ levels were measured by ELISA method. The plasma levels of HMGB1 and IFN-γ were significantly increased in lupus nephritis patients compared to HC (P < 0.05 and P < 0.01, respectively). Additionally, plasma HMGB1 was positively correlated with IFN-γ (P < 0.001), creatinine (P < 0.05), ESR (P < 0.05), 24-h urinary protein (P < 0.001), and negatively correlated with serum albumin (P < 0.05). HMGB1 and IFN-γ may contribute to the generation of lupus nephritis and may be a potential role for therapies targeting cytokines and HMGB1 in preventing or limiting lupus nephritis in the vulnerable SLE patients.
The Egyptian Rheumatologist | 2015
Tamer A. Gheita; Ghada S. Azkalany; Wafaa Gaber; Abeer Mohey
The Egyptian Rheumatologist | 2012
Ghada S. Azkalany; Tamer A. Gheita; Wafaa Gaber; Abeer Mohey
The Egyptian Rheumatologist | 2013
Wafaa Gaber; Ghada S. Azkalany; Tamer A. Gheita; Abeer Mohey; Randa Sabry
The Egyptian Rheumatologist | 2013
Yasser Ezzat; Wafaa Gaber; Sherif F. Abd El-Rahman; Marwa I. Ezzat; Mohammad El‑Sayed
The Egyptian Rheumatologist | 2013
Wafaa Gaber; Yasser Ezzat; Sherif Abdel Rahman
Clinical Rheumatology | 2014
Wafaa Gaber; Yasser Ezzat; Neveen M. El Fayoumy; Hanan Helmy; Abeer Mohey
The Egyptian Rheumatologist | 2012
Wafaa Gaber; Safaa Sayed; Hanaa M. Rady; Abeer Mohey